Recurrent Chylous Pleural Effusions in a Patient Treated With Dasatinib.

Author: Calavia LianoHugo, ManfrediChristopher, NasirSyed Alishan

Paper Details 
Original Abstract of the Article :
Dasatinib is a second-generation BCR-ABL tyrosine kinase inhibitor (TKI) that is approved for the treatment of chronic myeloid leukemia (CML), a myeloproliferative disorder seen commonly in adults over the age of 50. Dasatinib is superior in tolerance and efficacy to first-generation TKIs such as im...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450929/

データ提供:米国国立医学図書館(NLM)

Dasatinib and Chylous Pleural Effusions: A Unexpected Storm in the Desert of Cancer Treatment

Dasatinib, a medication used to treat chronic myeloid leukemia (CML), is a powerful tool in the fight against cancer. However, this case report describes a rare and challenging complication associated with dasatinib: recurrent chylous pleural effusions. These effusions occur when lymphatic fluid, normally found in the body's lymphatic system, leaks into the space between the lungs and the chest wall. It's like a hidden spring in the desert, unexpectedly bursting forth with fluid, disrupting the delicate balance of the body.

A Rare Storm: Navigating the Complications of Dasatinib

The study presents a case of a patient who experienced persistent chylous pleural effusions despite discontinuation of dasatinib, requiring repeated drainage procedures. It's like a persistent desert storm that refuses to abate, posing a significant challenge to the patient's health. This case highlights the need for vigilance and careful monitoring in patients receiving dasatinib, as well as the importance of exploring alternative treatment options if complications arise.

A Desert of Challenges: Managing Complicated Cases

This case underscores the complexity of cancer treatment and the importance of managing potential complications effectively. It's like navigating a vast and unforgiving desert, where unexpected storms can erupt at any moment. By understanding the potential challenges and developing effective strategies, we can improve the care and outcomes for patients facing difficult and complex medical situations.

Dr. Camel's Conclusion

This case report is like a sandstorm in the desert of cancer treatment, reminding us of the unpredictable nature of disease and the importance of vigilance. It highlights the challenges and complications that can arise during treatment, emphasizing the need for innovative approaches and compassionate care for patients navigating difficult journeys.

Date :
  1. Date Completed n.d.
  2. Date Revised 2022-09-17
Further Info :

Pubmed ID

36106302

DOI: Digital Object Identifier

PMC9450929

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.